alexa Aldar S. Bourinbaiar | Immunitor USA Inc.
ISSN: 2157-7560

Journal of Vaccines & Vaccination
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Aldar S. Bourinbaiar

Aldar S. Bourinbaiar Aldar S. Bourinbaiar
Immunitor USA Inc.

Aldar S. Bourinbaiar is CEO of Immunitor USA Inc., manufacturer and developer of oral vaccines. He received M.Sc. in Zoology/BioStatistics from National University of Mongolia, UlanBator, Mongolia. Trained in Computer Programming/Statistics, Jan Comenius University, Bratislava, Czechoslovakia, M.Sc. D.E.A. in Population Genetics Epidemiological Anthropology, University of Paris VII, Ph.D. 3eme cycle in Cancer Immunogenetics Cytogenetics, University of Paris VII, M.D./Ph.D. D.E.R.B.H. in Experimental Oncology, Transplantation and Cancer Immunology, KremlinBicetre Medical School, University of Paris XI, M.A. in Mongolian History and Civilization, Sorbonne Nouvelle, University of Paris III, Paris, France, B.A. in Russian Literature and Language, Sorbonne Nouvelle, University of Paris III, Paris, France. Fluent in Mongolian, Russian, French and English. Basic knowledge of Japanese, Slovak, and Thai. Fellow of Claude Bernard Association, Paris, France. Fellowship award from NATO Institute for Advanced Studies. Award of excellence in research by Hayashibara Biochemical Co., Japan. Published over 130 publications and 5 books. Six awarded US patents on antiviral and anticancer drugs. He is serving on editorial board of three peer reviewed journals. Elected as Thailands regional representative by International Organization on Biotechnology and Bioengineering, Stockholm, Sweden. Expert member of the Society of Industry Leaders, a division of Standard Poors, New York. NIH grant reviewer on AIDS related projects for 20052006 cycle. Listed in International Who is Who Professionals, Marquis Whos Who, Marquis Whos Who in Asia, Who is Who Historical Society, Cambridges 2000 Outstanding Intellectuals of 21st Century.

Research Interest

Immunophenotyping and cytohistochemistry. Flow cytometry and cell sorting. Fluorescence and electron microscopy. ELISA and radioimmunoprecipitation (RIPA) assays. Monoclonal antibody preparation and biotin labeling. Antibody-antigen interaction. Vaccine development. Immunoglobulin isotyping. CTL and MLR assays. Apoptosis. CTL cloning and limiting dilution assays. Cell adhesion assays. Characterization and culture of primary and established tumor cell lines. Inflammatory mediators. Leukocyte enzymes, cytokines, interferons, growth factors, neurotransmitters, and hormone assays. Reproductive physiology and endocrinology. Semen and sperm analysis. Signal transduction. Transmembrane transport. Endocytosis and phagocytosis. Preparation and extraction of DNA, RNA, and mRNA. Hirt extraction. Recombinant DNA methodology. Cloning and gene expression. Rabbit reticulocyte transcription/translation assay. CAT assay. Quantitative PCR and RT-PCR. Southern and Northern blot and gel analysis. Chromosome preparation and karyotyping. Isotopic and non-isotopic in situ hybridization and detection. Agarose and PAGE electrophoresis and Western blot. Protein purification, chromatography, chemistry and crystallization. Receptor binding and ligand radiolabeling. Functional and quantitative protease assays and identification. Topoisomerase assay. General microbiology and bacteriology. Methods for growth, isolation, purification, detection and quantitation of HIV, HTLV, and herpesviruses. Reverse transcriptase and integrase assays. In vitro assays for antiviral drugs and vaccines. Computer and statistical analysis of data related to clinical trials. Clinical trials organization. Grant writing and soliciting from public and private foundations. Extensive database search experience for gene and amino acid sequences.


Global Speakers in the subject

Global Experts in the subject


Phase 2 Trial of V-5 Immunitor (V5) in Patients with Chronic Hepatitis C Co-infected with HIV and Mycobacterium Tuberculosis
Olga V. Arjanova, Nathalia D. Prihoda, Larisa V. Yurchenko, Nina I. Sokolenko, Valery M. Frolov, Marina G Tarakanovskaya, Vichai Jirathitikal and Aldar S. Bourinbaiar
Research Article: J Vaccines Vaccin 2010, 1:103
DOI: 10.4172/2157-7560.1000103
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version